Skip to main content

OptiBiotix confirms plan to list skin care subsidiary

OptiBiotix confirms plan to list skin care subsidiary

Life sciences group OptiBiotix Health plc (LON:OPTI) has confirmed its majority owned SkinBioTherapeutics subsidiary is looking to list on AIM. The group has been gearing up for this ever since it announced plans to spin out the skin care business – formerly known as SkinBiotix – last summer.

Shortly after announcing the split, OptiBiotix brought in Martin Hunt as its new chairman, while Catherine O’Neill has since been appointed as chief executive to head up the new business.

See the article in full at ProactiveInvestors.co.uk

Contact Us

Online form

If you would like to speak to us about an investment opportunity or would like some information on how to invest with Seneca, please contact us and a member of the team will be pleased to help you.
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.
Visit Seneca Partners Website